Exploring the utility of recombinantly expressed snake venom serine protease toxins as immunogens for generating experimental snakebite antivenoms (2022)

First Author: Alomran N

Attributed to: Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments funded by FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2022.05.07.491032

Publication URI: http://dx.doi.org/10.1101/2022.05.07.491032

Type: Preprint